You have 9 free searches left this month | for more free features.

RCHOP

Showing 26 - 50 of 62

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diffuse Large B Cell Lymphoma Trial in Colchester, Canterbury, Nottingham (R-CHOP, R-CHOP + acalabrutinib)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Colchester, Essex, United Kingdom
  • +32 more
Oct 25, 2022

Secondary Prognostic Index in RefrActory Lymphoma

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • prognostic assessment
  • Le Mans, France
  • +1 more
Mar 18, 2021

DLBCL, Elderly Patients Trial in Italy (Vitamin D3 (Cholecalciferol), RCHOP o R-miniCHOP at standard doses)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • Elderly Patients
  • Vitamin D3 (Cholecalciferol)
  • RCHOP o R-miniCHOP at standard doses
  • Brescia, BS, Italy
  • +48 more
Jun 19, 2020

Pneumococcal Infections, Lymphoma, Large B-Cell, Diffuse Trial in Tours (Anti-pneumococcal vaccination with prime-boost strategy

Recruiting
  • Pneumococcal Infections
  • Lymphoma, Large B-Cell, Diffuse
  • Anti-pneumococcal vaccination with prime-boost strategy in patients with diffuse large B cell lymphoma
  • Tours, France
    GYAN
May 17, 2021

DLBCL Trial in Belgium, France (RCHOP21)

Completed
  • DLBCL
  • Antwerpen, Belgium
  • +82 more
Jul 10, 2020

Non-invasive Tumor Immunoglobulin Gene Next Generation

Unknown status
  • Lymphoma, Large B-Cell, Diffuse
  • IgNGS from circulating tumor DNA
  • Barcelona, Spain
    Hospital de la Santa Creu i Sant Pau
Jan 27, 2020

DLBCL, Drug Toxicity Trial in Madrid (Glucarpidase 1000 UNT [Voraxaze])

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Drug Toxicity
  • Glucarpidase 1000 UNT [Voraxaze]
  • Madrid, Spain
  • +1 more
Aug 31, 2021

Non-Hodgkin's Lymphoma Trial in New York (Etoposide, carboplatin, ifosfamide, Rituximab, Ifosfamide, Etoposide, Carboplatin,

Completed
  • Non-Hodgkin's Lymphoma
  • Etoposide, carboplatin, ifosfamide
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 23, 2022

Mantle Cell Lymphoma Trial in Worldwide (R-CHOP, R-CHOP / R-HAD, Rituximab)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Antwerpen, Belgium
  • +139 more
Jul 23, 2021

Diffuse Large B Cell Lymphoma Trial in France (Adapted physical activity)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Adapted physical activity
  • Besançon, France
  • +4 more
Oct 7, 2021

Lymphoma, B-cell, Lymphoma, Large B-cell, Diffuse Trial in Worldwide (brentuximab vedotin, rituximab, vincristine)

Terminated
  • Lymphoma, B-cell
  • Lymphoma, Large B-cell, Diffuse
  • brentuximab vedotin
  • +5 more
  • Phoenix, Arizona
  • +50 more
May 22, 2018

Diffuse Large B Cell Lymphoma Trial in Monterrey (Metformin)

Unknown status
  • Diffuse Large B Cell Lymphoma
  • Monterrey, Nuevo Leon, Mexico
    Hospital Universitario Dr. José Eleuterio González
Sep 19, 2018

Design of New Personalized Therapeutic Approaches for Diffuse

Unknown status
  • Diffuse Large B Cell Lymphoma
  • Gut microbiota samples
  • Meldola, FC, Italy
  • +1 more
Apr 12, 2019

Diffuse Large B Cell Lymphoma Trial in Shanghai (Lenalidomide 25mg)

Unknown status
  • Diffuse Large B Cell Lymphoma
  • Lenalidomide 25mg
  • Shanghai, Shanghai, China
    Ruijin hospital
Jul 4, 2019

Diffuse, Large B-Cell, Lymphoma Trial in Spain (Bortezomib, Rituximab, Cyclophosphamide)

Completed
  • Diffuse, Large B-Cell, Lymphoma
  • Zaragoza, Aragón, Spain
  • +20 more
Sep 18, 2018

Diffuse Large B Cell Lymphoma Trial in Calgary, Ottawa, Regina (Autologous Blood Stem Transplantation, R-CHOP)

Completed
  • Diffuse Large B Cell Lymphoma
  • Autologous Blood Stem Transplantation
  • R-CHOP
  • Calgary, Alberta, Canada
  • +2 more
Jan 17, 2019

Lymphoma Trial in Houston (Rituximab, Cyclophosphamide, Doxorubicin)

Completed
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 18, 2020

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Diffuse Trial in Boston (GM-CSF, CHOP, Rituximab)

Terminated
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Boston, Massachusetts
  • +2 more
Jan 16, 2018

Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP

Terminated
  • Lymphoma
  • Non-Hodgkin's Lymphoma
  • Stanford, California
    Stanford University School of Medicine
Jun 29, 2016

Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL) Trial in United States (Bortezomib, Rituximab,

Completed
  • Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
  • Beverly Hills, California
  • +69 more
Nov 14, 2016

Lymphoma Trial in Rochester (rituximab, cyclophosphamide, doxorubicin HCl)

Completed
  • Lymphoma
  • rituximab
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic Cancer Center
Aug 9, 2017

Lymphoma Trial in United States (rituximab, bortezomib, cyclophosphamide)

Completed
  • Lymphoma
  • rituximab
  • +5 more
  • Anchorage, Alaska
  • +146 more
Oct 3, 2017

Newly Diagnosed Diffuse Large B Cell Primary Breast Lymphomas

Terminated
  • Diffuse Large B-Cell Lymphoma of the Breast
    • (no location specified)
    Mar 10, 2017

    MANTLE CELL LYMPHOMA Trial in Italy, Portugal (Lenalidomide)

    Unknown status
    • MANTLE CELL LYMPHOMA
    • Mestre, VE, Italy
    • +52 more
    Feb 8, 2018

    Diffuse Large B Cell Lymphoma Trial in New York (rituximab, cyclophosphamide, vincristine)

    Completed
    • Diffuse Large B Cell Lymphoma
    • rituximab
    • +5 more
    • New York, New York
      Weill Cornell Medical College
    Feb 23, 2017